HEALTHSTORY 737· JULY 4, 2026

Roche Drug Sets New Standard for KRAS-Driven Lung Cancer

A Roche drug has established a new treatment standard for KRAS-driven lung cancer, STAT+ reported, marking a significant moment in an oncology target that has long resisted effective therapy. The news lands as the broader biotech sector's…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 736FBI Director Kash Patel Filed Late Disclosure on Strategy Stock, Reports Say NEXT STORY 738 →North Island Credit Union Collects School Backpacks for San Diego Youth Through Boys & Girls Clubs Partnership

Keep reading

More from the desk.

01HEALTH

ADA internal review clears group of censorship after members ejected in New Orleans

An internal review, meaning an investigation the organization runs into its own conduct using a committee it appoints, has cleared the American Diabetes Association of censoring five members ejected from its scientific conference in New…

health2 MIN

26HEALTH

GLP-1 drugs are forcing employers to reconsider how they pay for workers' health care

A class of prescription medications known as GLP-1 drugs is upending how employers pay for their workers' health coverage. STAT's Health Care Inc. newsletter, written by reporter Bob Herman, describes

health1 MIN

30HEALTH

A federal court will test whether buying a drug patent application can extend a monopoly illegally

Buying a patent application, a government filing that claims rights to an invention before the patent is officially issued, may be enough to cross the line into anticompetitive behavior. That question sits at the center of a federal…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk